Anavip
Antivenom for pit viper bites
| Drug Information | |||
|---|---|---|---|
| Image | |||
| Identifiers
CAS Number ATC Code PubChem DrugBank ChemSpider ID UNII KEGG ChEBI ChEMBL IUPAC Name |
Chemical Data
C H N O Molecular Weight | ||
Anavip is an antivenom used for the treatment of envenomation by pit vipers, including rattlesnakes. It is specifically designed to neutralize the venom of these snakes and is administered via intravenous infusion.
Composition[edit | edit source]
Anavip is composed of equine-derived F(ab')2 fragments of immunoglobulin G (IgG). These fragments are obtained from horses that have been immunized with the venom of pit vipers. The F(ab')2 fragments are purified and processed to remove the Fc portion of the antibody, reducing the risk of adverse immune reactions.
Indications[edit | edit source]
Anavip is indicated for the management of adult and pediatric patients with North American pit viper envenomation. This includes bites from various species of rattlesnakes, such as the western diamondback rattlesnake and the eastern diamondback rattlesnake.
Mechanism of Action[edit | edit source]
The F(ab')2 fragments in Anavip bind to and neutralize the toxic components of pit viper venom. This prevents the venom from causing further damage to tissues and organs, thereby mitigating the effects of the envenomation.
Administration[edit | edit source]
Anavip is administered intravenously. The initial dose is typically given as soon as possible after the bite, followed by additional doses as needed based on the patient's clinical response. The infusion should be monitored closely for any signs of adverse reactions.
Adverse Reactions[edit | edit source]
Common adverse reactions to Anavip include mild to moderate allergic reactions, such as rash, itching, and fever. Severe reactions, such as anaphylaxis, are rare but can occur. Patients should be monitored for any signs of hypersensitivity during and after the infusion.
Storage and Handling[edit | edit source]
Anavip should be stored in a refrigerator at temperatures between 2°C and 8°C (36°F and 46°F). It should not be frozen. The product should be protected from light and kept in its original packaging until ready for use.
See Also[edit | edit source]
Related Pages[edit | edit source]
 | This hospital-related article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
